TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2294882
log Bayes Factor = 81.5012
Chromosome 6   position 32,367,515  (GRCh37) Explore rs2294882 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C44.3 Skin of other and unspecified parts of face
1.000 0.000 0.000
E10.9 Without complications
0.000 0.000 1.000
J45.9 Asthma, unspecified
0.000 0.000 1.000
K51.9 Ulcerative colitis, unspecified
1.000 0.000 0.000
K90.0 Coeliac disease
0.000 0.000 1.000
C44 Other malignant neoplasms of skin
1.000 0.000 0.000
K51 Ulcerative colitis
1.000 0.000 0.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
K50.1 Crohn's disease of large intestine
1.000 0.000 0.000
K50 Crohn's disease [regional enteritis]
1.000 0.000 0.000
C44.7 Skin of lower limb, including hip
1.000 0.000 0.000
K50-K52 Noninfective enteritis and colitis
1.000 0.000 0.000
C44.4 Skin of scalp and neck
0.996 0.004 0.000
E10.1 With ketoacidosis
0.000 0.005 0.995
C44.2 Skin of ear and external auricular canal
0.989 0.011 0.000
E10.3 With ophthalmic complications
0.000 0.013 0.987
K50.9 Crohn's disease, unspecified
0.984 0.016 0.000
K51.2 Ulcerative (chronic) proctitis
0.979 0.021 0.000
K51.4 Pseudopolyposis of colon
0.972 0.028 0.000
C44.5 Skin of trunk
0.968 0.032 0.000
E10-E14 Diabetes mellitus
0.000 0.033 0.967
E16.2 Hypoglycaemia, unspecified
0.000 0.037 0.963
E16 Other disorders of pancreatic internal secretion
0.000 0.038 0.962
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.041 0.959
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.042 0.958
C44.6 Skin of upper limb, including shoulder
0.957 0.043 0.000
Z93.2 Ileostomy status
0.955 0.045 0.000
C44.0 Skin of lip
0.951 0.049 0.000
K51.8 Other ulcerative colitis
0.950 0.050 0.000
C44.1 Skin of eyelid, including canthus
0.913 0.087 0.000
E20-E35 Disorders of other endocrine glands
0.000 0.095 0.905
E27.1 Primary adrenocortical insufficiency
0.000 0.097 0.903
E27 Other disorders of adrenal gland
0.000 0.097 0.903
D86.9 Sarcoidosis, unspecified
0.000 0.103 0.897
D86 Sarcoidosis
0.000 0.112 0.888
D86.0 Sarcoidosis of lung
0.000 0.130 0.870
E10.4 With neurological complications
0.000 0.177 0.823
K51.5 Mucosal proctocolitis
0.810 0.190 0.000
D86.8 Sarcoidosis of other and combined sites
0.000 0.194 0.806
E10.8 With unspecified complications
0.000 0.207 0.793
K90 Intestinal malabsorption
0.000 0.208 0.792
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.213 0.787
E16.1 Other hypoglycaemia
0.000 0.218 0.782
D86.1 Sarcoidosis of lymph nodes
0.000 0.221 0.779
E10.2 With renal complications
0.000 0.225 0.775
E10.6 With other specified complications
0.000 0.230 0.770
E10.0 With coma
0.000 0.233 0.767
E00-E07 Disorders of thyroid gland
0.000 0.251 0.749
K52 Other non-infective gastro-enteritis and colitis
0.736 0.264 0.000
E27.2 Addisonian crisis
0.000 0.265 0.735
E03 Other hypothyroidism
0.000 0.266 0.734
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.270 0.730
E22 Hyperfunction of pituitary gland
0.000 0.272 0.728
E03.9 Hypothyroidism, unspecified
0.000 0.280 0.720
C44.8 Overlapping lesion of skin
0.717 0.283 0.000
E10.7 With multiple complications
0.000 0.283 0.717
E13 Other specified diabetes mellitus
0.000 0.283 0.717
K50.8 Other Crohn's disease
0.713 0.287 0.000
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.287 0.713
E24 Cushing's syndrome
0.000 0.298 0.702
E12 Malnutrition-related diabetes mellitus
0.000 0.307 0.693
C44.9 Malignant neoplasm of skin, unspecified
0.690 0.310 0.000
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.310 0.690
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.310 0.690
E16.4 Abnormal secretion of gastrin
0.000 0.310 0.690
E16.3 Increased secretion of glucagon
0.000 0.310 0.690
E15 Nondiabetic hypoglycaemic coma
0.000 0.312 0.688
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.325 0.675
E20 Hypoparathyroidism
0.000 0.339 0.661
E14 Unspecified diabetes mellitus
0.000 0.343 0.657
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.351 0.649
E32 Diseases of thymus
0.000 0.351 0.649
E31 Polyglandular dysfunction
0.000 0.351 0.649
E30 Disorders of puberty, not elsewhere classified
0.000 0.351 0.649
E25 Adrenogenital disorders
0.000 0.351 0.649
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.351 0.649
E27.5 Adrenomedullary hyperfunction
0.000 0.353 0.647
E27.0 Other adrenocortical overactivity
0.000 0.353 0.647
K51.0 Ulcerative (chronic) enterocolitis
0.642 0.358 0.000
K51.3 Ulcerative (chronic) rectosigmoiditis
0.639 0.361 0.000
D86.3 Sarcoidosis of skin
0.000 0.363 0.637
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes
0.000 0.363 0.637
K52.1 Toxic gastro-enteritis and colitis
0.632 0.368 0.000
E40-E46 Malnutrition
0.000 0.381 0.619
K52.3 Indeterminate colitis
0.616 0.384 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.389 0.611
E10.5 With peripheral circulatory complications
0.000 0.392 0.608
K90.8 Other intestinal malabsorption
0.000 0.395 0.605
K51.1 Ulcerative (chronic) ileocolitis
0.595 0.404 0.000
K90.9 Intestinal malabsorption, unspecified
0.000 0.411 0.589
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.416 0.584
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.423 0.577
K90.3 Pancreatic steatorrhoea
0.000 0.432 0.568
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.432 0.568
K90.1 Tropical sprue
0.000 0.432 0.568
E24.9 Cushing's syndrome, unspecified
0.000 0.444 0.556
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.450 0.550
K52.8 Other specified non-infective gastro-enteritis and colitis
0.538 0.462 0.000
E13.9 Without complications
0.000 0.463 0.537
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.463 0.537
E00 Congenital iodine-deficiency syndrome
0.000 0.463 0.537
E27.8 Other specified disorders of adrenal gland
0.000 0.463 0.536
E29 Testicular dysfunction
0.000 0.472 0.527
E03.8 Other specified hypothyroidism
0.000 0.473 0.527
E03.5 Myxoedema coma
0.000 0.473 0.526
E03.4 Atrophy of thyroid (acquired)
0.000 0.473 0.526
E03.3 Postinfectious hypothyroidism
0.000 0.473 0.526
E03.1 Congenital hypothyroidism without goitre
0.000 0.473 0.526
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.473 0.526
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.478 0.522
E22.8 Other hyperfunction of pituitary gland
0.000 0.478 0.522
E14.3 With ophthalmic complications
0.000 0.479 0.521
E65-E68 Obesity and other hyperalimentation
0.000 0.481 0.519
E13.8 With unspecified complications
0.000 0.486 0.514
E13.7 With multiple complications
0.000 0.486 0.514
E13.6 With other specified complications
0.000 0.486 0.514
E13.5 With peripheral circulatory complications
0.000 0.486 0.514
E13.4 With neurological complications
0.000 0.486 0.514
E13.3 With ophthalmic complications
0.000 0.486 0.514
E13.2 With renal complications
0.000 0.486 0.514
E13.1 With ketoacidosis
0.000 0.486 0.514
E13.0 With coma
0.000 0.486 0.514
E34 Other endocrine disorders
0.000 0.488 0.512
K52.2 Allergic and dietetic gastro-enteritis and colitis
0.507 0.493 0.000
E24.8 Other Cushing's syndrome
0.000 0.497 0.503
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.497 0.503
E24.3 Ectopic ACTH syndrome
0.000 0.497 0.503
E24.2 Drug-induced Cushing's syndrome
0.000 0.497 0.503
E24.1 Nelson's syndrome
0.000 0.497 0.503
E24.0 Pituitary-dependent Cushing's disease
0.000 0.497 0.503
E12.9 Without complications
0.000 0.503 0.497
E12.8 With unspecified complications
0.000 0.503 0.497
E12.7 With multiple complications
0.000 0.503 0.497
E12.6 With other specified complications
0.000 0.503 0.497
E12.5 With peripheral circulatory complications
0.000 0.503 0.497
E12.4 With neurological complications
0.000 0.503 0.497
E12.3 With ophthalmic complications
0.000 0.503 0.497
E12.2 With renal complications
0.000 0.503 0.497
E12.1 With ketoacidosis
0.000 0.503 0.497
E12.0 With coma
0.000 0.503 0.497
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.512 0.488
E20.9 Hypoparathyroidism, unspecified
0.000 0.513 0.486
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.519 0.481
E21.0 Primary hyperparathyroidism
0.000 0.525 0.475
E20.8 Other hypoparathyroidism
0.000 0.526 0.474
E20.1 Pseudohypoparathyroidism
0.000 0.526 0.474
E20.0 Idiopathic hypoparathyroidism
0.000 0.526 0.474
E14.6 With other specified complications
0.000 0.527 0.473
E14.8 With unspecified complications
0.000 0.529 0.471
E14.7 With multiple complications
0.000 0.529 0.471
E14.2 Withrenal complications
0.000 0.529 0.471
E14.1 With ketoacidosis
0.000 0.529 0.471
E14.0 With coma
0.000 0.529 0.471
E22.0 Acromegaly and pituitary gigantism
0.000 0.532 0.468
E25.9 Adrenogenital disorder, unspecified
0.000 0.534 0.465
E25.8 Other adrenogenital disorders
0.000 0.534 0.465
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.534 0.465
E30.9 Disorder of puberty, unspecified
0.000 0.534 0.465
E30.8 Other disorders of puberty
0.000 0.534 0.465
E30.1 Precocious puberty
0.000 0.534 0.465
E30.0 Delayed puberty
0.000 0.534 0.465
E31.9 Polyglandular dysfunction, unspecified
0.000 0.534 0.465
E31.8 Other polyglandular dysfunction
0.000 0.534 0.465
E31.1 Polyglandular hyperfunction
0.000 0.534 0.465
E31.0 Autoimmune polyglandular failure
0.000 0.534 0.465
E32.9 Disease of thymus, unspecified
0.000 0.534 0.465
E32.8 Other diseases of thymus
0.000 0.534 0.465
E32.1 Abscess of thymus
0.000 0.534 0.465
E32.0 Persistent hyperplasia of thymus
0.000 0.534 0.465
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.534 0.465
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.534 0.465
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.534 0.465
E22.1 Hyperprolactinaemia
0.000 0.535 0.465
E14.9 Without complications
0.000 0.543 0.457
E50-E64 Other nutritional deficiencies
0.000 0.549 0.451
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.556 0.443
E45 Retarded development following protein-energy malnutrition
0.000 0.556 0.443
E43 Unspecified severe protein-energy malnutrition
0.000 0.556 0.443
E42 Marasmic kwashiorkor
0.000 0.556 0.443
E41 Nutritional marasmus
0.000 0.556 0.443
E40 Kwashiorkor
0.000 0.556 0.443
K52.0 Gastro-enteritis and colitis due to radiation
0.443 0.557 0.000
E28 Ovarian dysfunction
0.000 0.558 0.441
J45 Asthma
0.000 0.560 0.440
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.562 0.438
E21.4 Other specified disorders of parathyroid gland
0.000 0.562 0.438
E21.2 Other hyperparathyroidism
0.000 0.562 0.438
E14.5 With peripheral circulatory complications
0.000 0.571 0.429
E14.4 With neurological complications
0.000 0.574 0.425
E05.5 Thyroid crisis or storm
0.000 0.581 0.419
E05.4 Thyrotoxicosis factitia
0.000 0.581 0.419
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.581 0.419
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.581 0.419
E06 Thyroiditis
0.000 0.583 0.416
E26 Hyperaldosteronism
0.001 0.584 0.415
E27.9 Disorder of adrenal gland, unspecified
0.001 0.598 0.402
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.391 0.609 0.000
E34.0 Carcinoid syndrome
0.000 0.611 0.388
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.615 0.385
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.615 0.385
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.615 0.385
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.615 0.385
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.615 0.385
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.615 0.385
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.615 0.385
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.615 0.385
E29.9 Testicular dysfunction, unspecified
0.000 0.622 0.378
E29.8 Other testicular dysfunction
0.000 0.622 0.378
E29.0 Testicular hyperfunction
0.000 0.622 0.378
E46 Unspecified protein-energy malnutrition
0.000 0.624 0.375
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.373 0.627 0.000
E67 Other hyperalimentation
0.000 0.628 0.372
E68 Sequelae of hyperalimentation
0.000 0.628 0.372
E23 Hypofunction and other disorders of pituitary gland
0.000 0.631 0.369
E66 Obesity
0.000 0.632 0.368
E05.8 Other thyrotoxicosis
0.000 0.632 0.368
E34.5 Androgen resistance syndrome
0.000 0.633 0.367
E34.4 Constitutional tall stature
0.000 0.633 0.367
E34.3 Short stature, not elsewhere classified
0.000 0.633 0.367
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.633 0.367
E34.1 Other hypersecretion of intestinal hormones
0.000 0.633 0.367
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.650 0.350
E53 Deficiency of other B group vitamins
0.000 0.654 0.346
E07 Other disorders of thyroid
0.000 0.662 0.338
C82.0 Small cleaved cell, follicular
0.334 0.666 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.676 0.323
E63 Other nutritional deficiencies
0.000 0.676 0.323
E56 Other vitamin deficiencies
0.000 0.676 0.323
E50 Vitamin A deficiency
0.000 0.676 0.323
E60 Dietary zinc deficiency
0.000 0.676 0.323
E59 Dietary selenium deficiency
0.000 0.676 0.323
E54 Ascorbic acid deficiency
0.000 0.676 0.323
E52 Niacin deficiency [pellagra]
0.000 0.676 0.323
E44.1 Mild protein-energy malnutrition
0.000 0.682 0.318
E44.0 Moderate protein-energy malnutrition
0.000 0.682 0.318
J45.0 Predominantly allergic asthma
0.000 0.682 0.318
E28.9 Ovarian dysfunction, unspecified
0.000 0.683 0.316
E28.8 Other ovarian dysfunction
0.000 0.683 0.316
E28.1 Androgen excess
0.000 0.683 0.316
E28.0 Oestrogen excess
0.000 0.683 0.316
J45.8 Mixed asthma
0.000 0.684 0.316
J45.1 Nonallergic asthma
0.000 0.684 0.316
K50.0 Crohn's disease of small intestine
0.315 0.685 0.000
E58 Dietary calcium deficiency
0.000 0.692 0.308
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.306 0.694 0.000
E34.8 Other specified endocrine disorders
0.000 0.695 0.304
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.302 0.698 0.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.701 0.299
E06.5 Other chronic thyroiditis
0.000 0.701 0.299
E06.4 Drug-induced thyroiditis
0.000 0.701 0.299
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.701 0.299
E06.1 Subacute thyroiditis
0.000 0.701 0.299
E06.0 Acute thyroiditis
0.000 0.701 0.299
E26.8 Other hyperaldosteronism
0.001 0.701 0.298
E26.1 Secondary hyperaldosteronism
0.001 0.701 0.298
D80-D89 Certain disorders involving the immune mechanism
0.000 0.702 0.298
E51 Thiamine deficiency
0.000 0.702 0.297
K52.9 Non-infective gastro-enteritis and colitis, unspecified
0.295 0.705 0.000
E06.9 Thyroiditis, unspecified
0.000 0.705 0.294
C83 Diffuse non-Hodgkin's lymphoma
0.292 0.708 0.000
C82.3 Follicular lymphoma grade IIIa
0.290 0.709 0.000
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.714 0.286
C82.2 Large cell, follicular
0.285 0.715 0.000
C83.3 Large cell (diffuse)
0.285 0.715 0.000
E23.6 Other disorders of pituitary gland
0.000 0.716 0.284
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.284 0.716 0.000
E53.8 Deficiency of other specified B group vitamins
0.000 0.717 0.283
E05.9 Thyrotoxicosis, unspecified
0.000 0.719 0.281
E34.9 Endocrine disorder, unspecified
0.000 0.720 0.280
E66.9 Obesity, unspecified
0.000 0.720 0.280
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.277 0.723 0.000
E11.1 With ketoacidosis
0.000 0.725 0.274
C43-C44 Melanoma and other malignant neoplasms of skin
0.271 0.729 0.000
E28.3 Primary ovarian failure
0.000 0.730 0.270
E61 Deficiency of other nutrient elements
0.000 0.730 0.270
C82.6 Cutaneous follicle centre lymphoma
0.268 0.732 0.000
C82.5 Diffuse follicle centre lymphoma
0.268 0.732 0.000
C82.4 Follicular lymphoma grade IIIb
0.268 0.732 0.000
E67.8 Other specified hyperalimentation
0.000 0.733 0.267
E67.3 Hypervitaminosis D
0.000 0.733 0.267
E67.2 Megavitamin-B6 syndrome
0.000 0.733 0.267
E67.1 Hypercarotenaemia
0.000 0.733 0.267
E67.0 Hypervitaminosis A
0.000 0.733 0.267
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.735 0.265
E23.1 Drug-induced hypopituitarism
0.000 0.735 0.265
E66.1 Drug-induced obesity
0.000 0.736 0.264
E29.1 Testicular hypofunction
0.000 0.743 0.256
E26.9 Hyperaldosteronism, unspecified
0.001 0.745 0.254
E66.8 Other obesity
0.000 0.746 0.254
C82.1 Mixed small cleaved and large cell, follicular
0.249 0.750 0.000
C83.1 Small cleaved cell (diffuse)
0.249 0.751 0.000
E23.7 Disorder of pituitary gland, unspecified
0.000 0.751 0.249
E53.1 Pyridoxine deficiency
0.000 0.752 0.248
E53.0 Riboflavin deficiency
0.000 0.752 0.248
E07.1 Dyshormogenetic goitre
0.000 0.757 0.242
E07.0 Hypersecretion of calcitonin
0.000 0.757 0.242
C83.2 Mixed small and large cell (diffuse)
0.239 0.761 0.000
D51 Vitamin B12 deficiency anaemia
0.000 0.764 0.236
Z93 Artificial opening status
0.236 0.764 0.000
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency
0.000 0.764 0.236
C95 Leukaemia of unspecified cell type
0.234 0.766 0.000
D50-D53 Nutritional anaemias
0.000 0.767 0.233
E50.9 Vitamin A deficiency, unspecified
0.000 0.768 0.232
E50.8 Other manifestations of vitamin A deficiency
0.000 0.768 0.232
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.768 0.232
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.768 0.232
E50.5 Vitamin A deficiency with night blindness
0.000 0.768 0.232
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.768 0.232
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.768 0.232
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.768 0.232
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.768 0.232
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.768 0.232
E56.9 Vitamin deficiency, unspecified
0.000 0.768 0.232
E56.8 Deficiency of other vitamins
0.000 0.768 0.232
E56.1 Deficiency of vitamin K
0.000 0.768 0.232
E56.0 Deficiency of vitamin E
0.000 0.768 0.232
E63.9 Nutritional deficiency, unspecified
0.000 0.768 0.232
E63.8 Other specified nutritional deficiencies
0.000 0.768 0.232
E63.1 Imbalance of constituents of food intake
0.000 0.768 0.232
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.768 0.232
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.768 0.232
E64.8 Sequelae of other nutritional deficiencies
0.000 0.768 0.232
E64.3 Sequelae of rickets
0.000 0.768 0.232
E64.2 Sequelae of vitamin C deficiency
0.000 0.768 0.232
E64.1 Sequelae of vitamin A deficiency
0.000 0.768 0.232
E64.0 Sequelae of protein-energy malnutrition
0.000 0.768 0.232
E21.3 Hyperparathyroidism, unspecified
0.000 0.768 0.232
E11.2 With renal complications
0.000 0.768 0.232
E53.9 Vitamin B deficiency, unspecified
0.000 0.771 0.229
E07.8 Other specified disorders of thyroid
0.000 0.772 0.227
E55 Vitamin D deficiency
0.000 0.779 0.220
E66.0 Obesity due to excess calories
0.000 0.780 0.220
D50.9 Iron deficiency anaemia, unspecified
0.000 0.780 0.220
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.219 0.781 0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
0.000 0.781 0.219
D50 Iron deficiency anaemia
0.000 0.783 0.217
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.217 0.783 0.000
C94 Other leukaemias of specified cell type
0.217 0.783 0.000
C93 Monocytic leukaemia
0.217 0.783 0.000
C86 Other specified types of T/NK-cell lymphoma
0.217 0.783 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.215 0.785 0.000
E11.7 With multiple complications
0.000 0.785 0.215
D82 Immunodeficiency associated with other major defects
0.000 0.786 0.214
D81 Combined immunodeficiencies
0.000 0.786 0.214
E65 Localised adiposity
0.001 0.786 0.213
E51.9 Thiamine deficiency, unspecified
0.000 0.786 0.213
E51.8 Other manifestations of thiamine deficiency
0.000 0.786 0.213
E51.1 Beriberi
0.000 0.786 0.213
E11.6 With other specified complications
0.000 0.787 0.213
C85.1 B-cell lymphoma, unspecified
0.210 0.790 0.000
C83.6 Undifferentiated (diffuse)
0.209 0.791 0.000
C83.5 Lymphoblastic (diffuse)
0.209 0.791 0.000
C83.4 Immunoblastic (diffuse)
0.209 0.791 0.000
D51.9 Vitamin B12 deficiency anaemia, unspecified
0.000 0.791 0.209
C81 Hodgkin's disease
0.207 0.793 0.000
E61.2 Magnesium deficiency
0.000 0.793 0.206
E11.8 With unspecified complications
0.000 0.794 0.206
E23.2 Diabetes insipidus
0.000 0.796 0.203
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.203 0.796 0.000
C85.0 Lymphosarcoma
0.203 0.796 0.000
E28.2 Polycystic ovarian syndrome
0.000 0.800 0.200
M45.X9 Ankylosing spondylitis (Site unspecified)
0.200 0.800 0.000
Z93.8 Other artificial opening status
0.199 0.801 0.000
E61.9 Deficiency of nutrient element, unspecified
0.000 0.806 0.193
E61.8 Deficiency of other specified nutrient elements
0.000 0.806 0.193
E61.7 Deficiency of multiple nutrient elements
0.000 0.806 0.193
E61.6 Vanadium deficiency
0.000 0.806 0.193
E61.5 Molybdenum deficiency
0.000 0.806 0.193
E61.4 Chromium deficiency
0.000 0.806 0.193
E61.3 Manganese deficiency
0.000 0.806 0.193
E61.0 Copper deficiency
0.000 0.806 0.193
D83 Common variable immunodeficiency
0.000 0.807 0.193
C90 Multiple myeloma and malignant plasma cell neoplasms
0.193 0.807 0.000
C95.0 Acute leukaemia of unspecified cell type
0.190 0.810 0.000
C83.7 Burkitt's tumour
0.189 0.811 0.000
E51.2 Wernicke's encephalopathy
0.000 0.812 0.187
Z93.6 Other artificial openings of urinary tract status
0.188 0.812 0.000
E06.3 Autoimmune thyroiditis
0.000 0.813 0.186
C88 Malignant immunoproliferative diseases
0.184 0.816 0.000
D80 Immunodeficiency with predominantly antibody defects
0.000 0.818 0.182
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.180 0.820 0.000
E11.0 With coma
0.000 0.821 0.178
E11.5 With peripheral circulatory complications
0.000 0.827 0.173
D84 Other immunodeficiencies
0.001 0.827 0.172
D52 Folate deficiency anaemia
0.000 0.828 0.171
Z93.9 Artificial opening status, unspecified
0.171 0.828 0.000
D51.8 Other vitamin B12 deficiency anaemias
0.000 0.830 0.169
D51.3 Other dietary vitamin B12 deficiency anaemia
0.000 0.830 0.169
D51.2 Transcobalamin II deficiency
0.000 0.830 0.169
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria
0.000 0.830 0.169
C84.0 Mycosis fungoides
0.169 0.831 0.000
C95.7 Other leukaemia of unspecified cell type
0.168 0.832 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.168 0.832 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.168 0.832 0.000
C81.1 Nodular sclerosis
0.163 0.837 0.000
D53 Other nutritional anaemias
0.000 0.838 0.162
C95.9 Leukaemia, unspecified
0.161 0.839 0.000
E26.0 Primary hyperaldosteronism
0.002 0.840 0.158
Z93.1 Gastrostomy status
0.160 0.840 0.000
C81.2 Mixed cellularity
0.158 0.841 0.000
E55.0 Rickets, active
0.000 0.842 0.158
C81.0 Lymphocytic predominance
0.156 0.844 0.000
D50.1 Sideropenic dysphagia
0.000 0.844 0.156
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.156 0.844 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.156 0.844 0.000
C86.4 Blastic NK-cell lymphoma
0.156 0.844 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.156 0.844 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.156 0.844 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.156 0.844 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.156 0.844 0.000
C93.9 Monocytic leukaemia, unspecified
0.156 0.844 0.000
C93.7 Other monocytic leukaemia
0.156 0.844 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.156 0.844 0.000
C93.2 Subacute monocytic leukaemia
0.156 0.844 0.000
C93.1 Chronic monocytic leukaemia
0.156 0.844 0.000
C93.0 Acute monocytic leukaemia
0.156 0.844 0.000
C94.7 Other specified leukaemias
0.156 0.844 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.156 0.844 0.000
C94.5 Acute myelofibrosis
0.156 0.844 0.000
C94.4 Acute panmyelosis
0.156 0.844 0.000
C94.3 Mast cell leukaemia
0.156 0.844 0.000
C94.2 Acute megakaryoblastic leukaemia
0.156 0.844 0.000
C94.1 Chronic erythraemia
0.156 0.844 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.156 0.844 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.156 0.844 0.000
C96.8 Histiocytic sarcoma
0.156 0.844 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.156 0.844 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.156 0.844 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.156 0.844 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.156 0.844 0.000
C96.3 True histiocytic lymphoma
0.156 0.844 0.000
C96.2 Malignant mast cell tumour
0.156 0.844 0.000
C96.1 Malignant histiocytosis
0.156 0.844 0.000
C96.0 Letterer-Siwe disease
0.156 0.844 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.154 0.846 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.154 0.846 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.154 0.846 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.154 0.846 0.000
C84.3 Lymphoepithelioid lymphoma
0.154 0.846 0.000
C84.2 T-zone lymphoma
0.154 0.846 0.000
C84.1 Sezary's diease
0.154 0.846 0.000
D81.9 Combined immunodeficiency, unspecified
0.000 0.846 0.153
D81.8 Other combined immunodeficiencies
0.000 0.846 0.153
D81.7 Major histocompatibility complex class II deficiency
0.000 0.846 0.153
D81.6 Major histocompatibility complex class I deficiency
0.000 0.846 0.153
D81.5 Purine nucleoside phosphorylase [PNP] deficiency
0.000 0.846 0.153
D81.4 Nezelof's syndrome
0.000 0.846 0.153
D81.3 Adenosine deaminase [ADA] deficiency
0.000 0.846 0.153
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
0.000 0.846 0.153
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
0.000 0.846 0.153
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis
0.000 0.846 0.153
D82.9 Immunodeficiency associated with major defect, unspecified
0.000 0.846 0.153
D82.8 Immunodeficiency associated with other specified major defects
0.000 0.846 0.153
D82.4 Hyperimmunoglobulin E [IgE] syndrome
0.000 0.846 0.153
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus
0.000 0.846 0.153
D82.2 Immunodeficiency with short-limbed stature
0.000 0.846 0.153
D82.1 Di George's syndrome
0.000 0.846 0.153
D82.0 Wiskott-Aldrich syndrome
0.000 0.846 0.153
E11.3 With ophthalmic complications
0.000 0.847 0.153
Z93.0 Tracheostomy status
0.152 0.848 0.000
Z93.4 Other artificial openings of gastro-intestinal tract status
0.149 0.851 0.000
C90.1 Plasma cell leukaemia
0.149 0.851 0.000
C81.7 Other Hodgkin's disease
0.149 0.851 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.149 0.851 0.000
C81.3 Lymphocytic depletion
0.149 0.851 0.000
M45 Ankylosing spondylitis
0.148 0.852 0.000
C84.4 Peripheral T-cell lymphoma
0.146 0.854 0.000
C84.5 Other and unspecified T-cell lymphomas
0.142 0.858 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.141 0.859 0.000
D83.8 Other common variable immunodeficiencies
0.000 0.861 0.138
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells
0.000 0.861 0.138
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
0.000 0.861 0.138
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
0.000 0.861 0.138
C90.3 Solitary plasmacytoma
0.138 0.861 0.000
C92 Myeloid leukaemia
0.135 0.865 0.000
C90.0 Multiple myeloma
0.133 0.867 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.132 0.868 0.000
C88.7 Other malignant immunoproliferative diseases
0.132 0.868 0.000
C88.3 Immunoproliferative small intestinal disease
0.132 0.868 0.000
C88.2 Gamma heavy chain disease
0.132 0.868 0.000
C88.1 Alpha heavy chain disease
0.132 0.868 0.000
M45.X2 Ankylosing spondylitis (Cervical region)
0.132 0.868 0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified
0.000 0.869 0.131
D80.8 Other immunodeficiencies with predominantly antibody defects
0.000 0.869 0.131
D80.7 Transient hypogammaglobulinaemia of infancy
0.000 0.869 0.131
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
0.000 0.869 0.131
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]
0.000 0.869 0.131
D80.4 Selective deficiency of immunoglobulin M [IgM]
0.000 0.869 0.131
D80.0 Hereditary hypogammaglobulinaemia
0.000 0.869 0.131
E11.4 With neurological complications
0.000 0.869 0.130
D80.1 Nonfamilial hypogammaglobulinaemia
0.000 0.870 0.130
D55-D59 Haemolytic anaemias
0.000 0.870 0.130
D52.9 Folate deficiency anaemia, unspecified
0.000 0.872 0.128
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.127 0.873 0.000
C91 Lymphoid leukaemia
0.126 0.873 0.001
Z93.3 Colostomy status
0.125 0.875 0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses
0.000 0.875 0.124
D84.8 Other specified immunodeficiencies
0.001 0.876 0.123
D84.1 Defects in the complement system
0.001 0.876 0.123
D84.0 Lymphocyte function antigen-1 [LFA-1] defect
0.001 0.876 0.123

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.